We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
+14.08%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$92.3M
AUM Growth
-$3.73M
Cap. Flow
-$14.8M
Cap. Flow %
-15.99%
Top 10 Hldgs %
99.23%
Holding
52
New
28
Increased
–
Reduced
3
Closed
13

Top Buys

Rank Stock Value
1
ONC
BeOne Medicines Ltd
ONC
+$3.5M
2
PINS icon
Pinterest
PINS
+$170K
3
RP
RealPage, Inc.
RP
+$131K
4
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$47.8K
5
TRU icon
TransUnion
TRU
+$46.1K

Top Sells

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$12.6M
2
SOLY
Soliton, Inc.
SOLY
+$2.57M
3
VT icon
Vanguard Total World Stock ETF
VT
+$996K
4
CHRS icon
Coherus Oncology
CHRS
+$753K
5
APEN
Apollo Endosurgery, Inc.
APEN
+$694K

Sector Composition

Rank Sector Weight
1 Healthcare 76.51%
2 Miscellaneous 17.11%
3 Technology 5.93%
4 Communication Services 0.23%
5 Industrials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSHA icon
1
Taysha Gene Therapies
TSHA
$1.52B
$53.1M 57.48%
2,000,000
– –
VT icon
2
Vanguard Total World Stock ETF
VT
$81.7B
$15.7M 17.05%
170,025
-11,481
-6% -$996K
IMTX icon
3
Immatics
IMTX
$1.27B
$7.53M 8.15%
697,431
– –
TXN icon
4
Texas Instruments
TXN
$254B
$5.25M 5.69%
32,000
– –
ONC
5
BeOne Medicines Ltd
ONC
$40.8B
$3.29M 3.56%
+12,715
New +$3.5M
TFFP
6
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$3.16M 3.42%
8,827
– –
SYRE icon
7
Spyre Therapeutics
SYRE
$7.56B
$2.2M 2.38%
11,187
– –
SOLY
8
DELISTED
Soliton, Inc.
SOLY
$864K 0.94%
112,552
-312,448
-74% -$2.57M
PLXP
9
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$346K 0.37%
62,673
– –
PINS icon
10
Pinterest
PINS
$10.7B
$187K 0.2%
+2,842
New +$170K
RP
11
DELISTED
RealPage, Inc.
RP
$174K 0.19%
+2,000
New +$131K
LXRX icon
12
Lexicon Pharmaceuticals
LXRX
$796M
$122K 0.13%
35,714
– –
APEN
13
DELISTED
Apollo Endosurgery, Inc.
APEN
$53K 0.06%
15,601
-263,436
-94% -$694K
IWF icon
14
iShares Russell 1000 Growth ETF
IWF
$129B
$51K 0.06%
+840
New +$47.8K
TRU icon
15
TransUnion
TRU
$13.3B
$50K 0.05%
+504
New +$46.1K
RTX icon
16
RTX Corp
RTX
$255B
$43K 0.05%
+600
New +$39.4K
WYNN icon
17
Wynn Resorts
WYNN
$8.35B
$39K 0.04%
+350
New +$32.3K
CUB
18
DELISTED
Cubic Corporation
CUB
$24K 0.03%
+380
New +$23.1K
OTIS icon
19
Otis Worldwide
OTIS
$25.1B
$20K 0.02%
+300
New +$19.5K
VZ icon
20
Verizon
VZ
$196B
$19K 0.02%
+315
New +$18.7K
HBI
21
DELISTED
Hanesbrands
HBI
$16K 0.02%
+1,075
New +$16.2K
AAPL icon
22
Apple
AAPL
$4.98T
$12K 0.01%
+88
New +$10.6K
BAX icon
23
Baxter International
BAX
$12.1B
$10K 0.01%
+125
New +$9.9K
BL icon
24
BlackLine
BL
$1.63B
$10K 0.01%
+75
New +$8.37K
SURF
25
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$9K 0.01%
+1,000
New +$8.69K
1
2 3

Similar funds

HP
Hound Partners New York $863M AUM 11.22% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $863M AUM 3.58% 1-Year Est. Return
BWA
BlueSky Wealth Advisors New Bern, North Carolina $863M AUM 17.63% 1-Year Est. Return
NEAM
New England Asset Management Farmington, Connecticut $863M AUM 17.57% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
BM
Berman McAleer Timonium, Maryland $864M AUM 22.02% 1-Year Est. Return
DOA
D'Orazio & Associates Falls Church, Virginia $864M AUM 21.64% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $864M AUM 15.83% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q4 2020 Portfolio in Review

As of Q4 2020, University of Texas/Texas AM Investment Management Co (UTIMCO) held 52 positions worth $92.3M, down 3.9% from $96.1M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) withdrew a net $14.8M in Q4 2020, closing 13 positions and reducing 3 holdings. Its most notable exit was Castle Biosciences, an estimated $12.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 79% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in BeOne Medicines Ltd worth $3.29M.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q4 2020 buy was BeOne Medicines Ltd: 12,715 shares worth $3.29M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q4 2020 reduction was Soliton, Inc., cutting an estimated $2.57M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Castle Biosciences in Q4 2020, selling an estimated $12.6M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 99% of its $92.3M portfolio in Q4 2020.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 28 new positions and closed 13 in Q4 2020.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value fell 3.9% quarter-over-quarter to $92.3M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2020, filed 5 Feb 2021.